“ISCHEMIA REPERFUSION INJURY AND IMMUNE MODULATION: NEW INSIGHTS INTO PATHOGENESIS AND THERAPY” (2026) Current Pharmaceutical Research, 2(1), pp. 83–99. doi:10.63785/6stsk452.